Applied UV (AUVI) IPOs and skyrockets 100%
Applied UV (AUVI) , an infection prevention technology company that applies the power of narrow-range ultra violet light (“UVC”) to destroy pathogens safely, thoroughly, and
August 31, 2020
John Willis
VBI Vaccines (VBIV) skyrockets on planned coronavirus vaccine
The objectives of the VBI Vaccines (VBIV) preclinical studies, which evaluated antibody binding titers and neutralizing antibody titers across a number of vaccine constructs, were
August 27, 2020
FDA & Trump approves emergency use authorization for convalescent plasma, here are stocks to watch this week
The FDA and Trump has approved yesterday the emergency use authorization of convalescent plasma for treatment of COVID-19 patients. A recent Stanford study gives a
August 24, 2020
CureVac (CVAC) Backed By Bill Gates, Goes Public Today
CureVac (CVAC) is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA). The company’s focus is on developing vaccines
August 14, 2020
Groupon (GRPN) beats earnings expectations, surges 64%
Groupon (GRPN) beats expectations set by Wall Street and has surged 64%. Analysts had predicted Groupon would lose $2.75 per share in its second quarter
August 10, 2020
Conduent (CNDT) reports stronger positive earnings, skyrockets 70%
Conduent (CNDT) reported strong positive earnings with significantly new business signings and skyrockets 70%, Cliff Skelton, Conduent CEO, stated “We continued to make progress in
August 7, 2020
American Virtual Cloud (AVCT) stock skyrockets 100% on acquisition of Ribbon’s Kandy Communications Business
American Virtual Cloud (AVCT) and Ribbon communications today announced that they have entered into a definitive agreement for AVCTechnologies to acquire Kandy Communications an industry-leading
August 6, 2020
Co Diagnostics (CODX) surges 10% on FDA authorized self collected COVID-19 saliva test
Co Diagnostics (CODX) a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its partner, Clinical Reference
August 3, 2020
Sonnet BioTherapeutics (SONN) skyrockets 100% on Relief Therapeutic FDA grant
Sonnet BioTherapeutics skyrockets 100% on FDA Expanded Access Protocol grant for RLF-100 (Aviptadil) for Respiratory Failure in COVID-19 by it’s subsidiary Relief Therapeutics. Relief Therapeutics
July 31, 2020
Microsoft (MSFT) to announce Inpixon (INPX) Partnership
There is a rumor going around that Microsoft (MSFT) and Inpixon (INPX) could announce a partnership agreement. One of our sources has released information detailing
July 27, 2020
Contributing Writers Wanted
Stockpence is currently seeking to expand our team of contributors. We’re looking for financial gurus & article writers to write about trending market news and investment ideas about the stock market.
If you’re interested please contact us!
Categories
Menu
